Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Anorexia 4Weight Loss 2Neoplasms 2Cachexia 2Sleep Initiation and Maintenance Disorders 1Depression 1Carcinoma, Non-Small-Cell Lung 1Body Weight 1Anorexia Nervosa with Significantly Low Body Weight 1

Interventions

Nutrition Assessment 1Mirtazapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Body Weight × Mirtazapine × Clear all
NCT00832520 2018-04-10

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

New Mexico Cancer Research Alliance

Phase 2 Terminated
13 enrolled 4 charts

Body Weight, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡